Differential cytotoxicity of Combretastatins A1 and A4 in two daunorubicin-resistant P388 cell lines-Reference-Cited by-同舟云学术

Differential cytotoxicity of Combretastatins A1 and A4 in two daunorubicin-resistant P388 cell lines

Published:1990-03 Issue:1 Volume:26 Page:79-81
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

McGown Alan T.,Fox Brian W.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/BF02940301.pdf

Reference8 articles.

1. Capranico G, Dasdia T, Zunino F (1986) Comparison of doxorubicin-induced DNA damage in doxorubicin-sensitive and -resistant P388 murine leukemia cells. Int J Cancer 37: 227

2. Cornwell MM, Pastan I, Gottesman MM (1987) Certain calcium channel blockers bind specifically to multidrug-resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein. J Biol Chem 262: 2166

3. Kessel D, Wilberding C (1984) Interactions between calcium antagonists, calcium fluxes and anthracycline transport. Cancer Lett 25: 97

4. McGown AT, Fox BW (1983) Comparative studies of the uptake of daunorubicin in sensitive and resistant cell lines by flow cytometry and biochemical extraction procedures. Cancer Chemother Pharmacol 11: 113

5. McGown AT, Fox BW (1989) Structural and biochemical comparison of the anti-mitotic agents colchicine, combretastatin A4 and amphethinile. Anti-Cancer Drug Des 3: 249

Cited by 139 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, concise synthesis and evaluation of novel amide-based combretastatin A-4 analogues as potent tubulin inhibitors;Bioorganic & Medicinal Chemistry Letters;2024-08

2. Discovery, synthesis, activities, structure–activity relationships, and clinical development of combretastatins and analogs as anticancer drugs. A comprehensive review;Natural Product Reports;2024

3. Synthesis by diastereomeric resolution, biochemical evaluation and molecular modelling of chiral 3-hydroxyl b-lactam microtubule-targeting agents for the treatment of triple negative breast and chemoresistant colorectal cancers;Bioorganic Chemistry;2023-12

4. Discovery of novel 2-(trifluoromethyl)quinolin-4-amine derivatives as potent antitumor agents with microtubule polymerization inhibitory activity;Bioorganic Chemistry;2023-10

5. The use of African medicinal plants in cancer management;Frontiers in Pharmacology;2023-02-14